tifluadom has been researched along with sincalide in 1 studies
| Studies (tifluadom) | Trials (tifluadom) | Recent Studies (post-2010) (tifluadom) | Studies (sincalide) | Trials (sincalide) | Recent Studies (post-2010) (sincalide) |
|---|---|---|---|---|---|
| 78 | 0 | 0 | 4,015 | 72 | 533 |
| Protein | Taxonomy | tifluadom (IC50) | sincalide (IC50) |
|---|---|---|---|
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.0006 | |
| Cholecystokinin receptor type A | Homo sapiens (human) | 0.0006 | |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.001 | |
| Gastrin/cholecystokinin type B receptor | Mus musculus (house mouse) | 0.0008 | |
| Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | 0.0004 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bock, MG; Chang, RS; Chen, TB; DiPardo, RM; Evans, BE; Freidinger, RM; Lotti, VJ; Rittle, KE; Veber, DF; Whitter, WL | 1 |
1 other study(ies) available for tifluadom and sincalide
| Article | Year |
|---|---|
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom.
Topics: Animals; Benzodiazepines; Brain; Cerebral Cortex; Chemical Phenomena; Chemistry; Cholecystokinin; Dihydromorphine; Guinea Pigs; Molecular Structure; Naloxone; Pancreas; Rats; Receptors, Cholecystokinin; Receptors, Opioid; Receptors, Opioid, kappa; Sincalide | 1990 |